申请人:Tosoh Corporation
公开号:US05330991A1
公开(公告)日:1994-07-19
Tetrahydroisoquinoline derivatives of the following formula [I] and acid addition salts thereof, and ##STR1## (wherein in all of these formulae, R.sup.1 represents C.sub.1 -C.sub.5 straight or branched alkyl, C.sub.2 -C.sub.5 straight or branched alkenyl or C.sub.2 -C.sub.5 straight or branched alkynyl; R.sup.2 represents hydrogen atom, C.sub.1 -C.sub.10 straight or branched alkyl, C.sub.2 -C.sub.10 straight or branched alkenyl, C.sub.2 -C.sub.10 straight or branched alkynyl, C.sub.1 -C.sub.10 straight or branched alkoxy, C.sub.2 -C.sub.10 straight or branched alkenyloxy, C.sub.2 -C.sub.10 straight or branched alkynyloxy, or C.sub.1 -C.sub.10 straight or branched halogenated alkyl; R.sup.3, R.sup.4 R.sup.5 and R.sup.6, the same or different represent hydrogen atom, C.sub.1 -C.sub.10 straight or branched alkyl, C.sub.2 -C.sub.10 straight or branched alkenyl, C.sub.2 -C.sub.10 straight or branched alkynyl, C.sub.1 -C.sub.10 straight or branched alkoxy, C.sub.2 -C.sub.10 straight or branched alkenyloxy, C.sub.2 -C.sub.10 straight or branched alkynyloxy or halogen atom, with the proviso that R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are not hydrogen atoms simultaneously).
以下式[I]的四氢异喹啉衍生物及其酸加成盐,以及##STR1##(在所有这些式子中,R1代表C1-C5直链或支链烷基,C2-C5直链或支链烯基或C2-C5直链或支链炔基;R2代表氢原子,C1-C10直链或支链烷基,C2-C10直链或支链烯基,C2-C10直链或支链炔基,C1-C10直链或支链烷氧基,C2-C10直链或支链烯氧基,C2-C10直链或支链炔氧基或C1-C10直链或支链卤代烷基; R3,R4,R5和R6相同或不同,代表氢原子,C1-C10直链或支链烷基,C2-C10直链或支链烯基,C2-C10直链或支链炔基,C1-C10直链或支链烷氧基,C2-C10直链或支链烯氧基,C2-C10直链或支链炔氧基或卤原子,但R3,R4,R5和R6不能同时为氢原子)。